Heart Health Journey: Coronary CT Angiogram (CCTA) with Cleerly Analysis
Heart Disease: The Leading Cause of Death for Both Men and Women
HealthLab providers have conducted consultations and heart scans for hundreds of satisfied patients, discovering that over 90% are affected by heart disease. The key is determining the extent of the disease and guiding patients through treatments that can prevent heart attacks.
CCTA Could Be Life-Saving
Our team delivers rapid results from your non-invasive CCTA scan, offering critical insights. Our expert providers will clearly communicate the findings, helping you take action to protect your heart health.
Physician Supervision
Concierge Support
Key Journey Details
Non-invasive and Accurate: CCTA (Coronary Computed Tomography Angiography) is a non-invasive imaging test that creates 3D images of the heart’s arteries, allowing doctors to detect plaque buildup and assess heart disease risks without surgery or invasive procedures.
Early Detection of Plaque: The test can identify different types of arterial plaque, including dangerous non-calcified plaques that may rupture and lead to heart attacks. Detecting these early can help in preventing future cardiac events.
Quick and Simple Procedure: The entire scan, including preparation, takes around 15 minutes. Patients are positioned in the CT scanner, may receive a contrast injection, and are usually asked to hold their breath briefly during the scan to ensure clear images.
Safe and Comfortable: CCTA is a well-tolerated procedure, with minimal discomfort. Any side effects from the contrast, such as a warm sensation or metallic taste, are temporary.
Guiding Personalized Treatment: Based on the results, your doctor can develop a personalized treatment plan, often involving lifestyle changes or medications like statins, to stabilize plaques and reduce future risk.
Peer-Reviewed Research
-
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults. Circulation. November 2010.
-
Preventing myocardial infarction in the young adult in the first place: how do the national cholesterol education panel iii guidelines perform? Journal of the American College of Cardiology. May 2003.
-
Coronary Atherosclerotic Precursors of Acute Coronary Syndromes. Journal of the American College of Cardiology. June 2018.
Frequently Asked Questions
-
A Cleerly heart scan analysis provides a detailed look at the presence, amount, and type of plaque in your heart’s arteries, using coronary computed tomography angiography (CCTA). The images from the CCTA are processed by Cleerly’s advanced AI software, which translates the data into measurements and reports for your doctor to review. This analysis gives you and your physician a clear picture of your plaque levels and types, helping to assess heart attack risk and guide personalized treatment plans, including lifestyle changes or medications. Cleerly can also identify arterial narrowing (stenosis), which can impede blood flow and lead to symptoms like chest pain or heart failure.
-
Plaque is a key factor in atherosclerosis, a condition where substances like fat, cholesterol, and calcium accumulate inside the arteries. Over time, plaque can reduce or even block blood flow to the heart, which significantly increases the risk of heart attacks. Certain types of plaque, especially non-calcified, low-density plaques, are more prone to rupture and cause a heart attack. The good news is that these plaques can often be stabilized with lifestyle changes and medical treatments. Cleerly helps you track the percentage of non-calcified plaque and monitor its stability over time.
-
Coronary computed tomography angiography (CCTA) is a specialized imaging test that assesses the heart’s blood vessels for plaque buildup. It uses computed tomography (CT), commonly known as a CT or CAT scan, to create multiple images of your heart and its arteries. These images can be analyzed in 3D, providing detailed insight into the condition of your coronary arteries.
-
As Cleerly is a new diagnostic test, it is not yet fully covered by insurance. Pricing may vary depending on the provider. We recommend discussing costs directly with your doctor and imaging center. If you have heart disease symptoms, some portions of your scan may be covered by insurance.
-
Many traditional heart disease tests, such as those for cholesterol or blood pressure, do not directly detect the presence of heart disease but instead assess risk factors. Shockingly, 70% of heart attack patients were considered "low-risk" by these conventional measures, and more than 90% of stress tests yield normal results. Cleerly uses CCTA, a non-invasive and highly accurate heart scan, to directly analyze plaque levels. This technology allows doctors to make informed decisions about treatment, whether that means additional testing or preventive measures.
-
Cleerly is designed for people who have symptoms of heart disease or those who believe they are at risk, even if they don’t yet have symptoms. Current medical guidelines suggest CCTA as an appropriate test for individuals experiencing chest pain.
-
Cleerly’s technology is backed by over 10 million images from more than 30,000 patients collected over 15 years in multi-center clinical trials. Our AI-driven plaque analysis has been FDA-cleared, and multiple trials have confirmed Cleerly’s accuracy in diagnosing heart disease. These trials demonstrate that Cleerly surpasses all existing clinical gold standards in detecting coronary artery disease.